Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $18.1800 (3.89%) ($17.3300 - $18.4300) on Mon. Mar. 30, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.64% (three month average) | RSI | 45 | Latest Price | $18.1800(3.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.6% a day on average for past five trading days. | Weekly Trend | HALO advances 1.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(50%) IWM(46%) ARKG(44%) IWC(44%) | Factors Impacting HALO price | HALO will decline at least -1.82% in a week (0% probabilities). VIXM(-31%) VXX(-15%) UUP(-14%) TLT(-2%) TBT(3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.82% (StdDev 3.64%) | Hourly BBV | 0 () | Intraday Trend | 2.5% | | | |
|
5 Day Moving Average | $17.43(4.3%) | 10 Day Moving Average | $16.42(10.72%) | 20 Day Moving Average | $17.36(4.72%) | To recent high | -16.7% | To recent low | 30.8% | Market Cap | $2.485b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |